Both projects aim to develop cost-effective, safe, non-invasive health solutions that can be conveniently included in the pig's feed. (Image source: Renaissance Bioscience)
Leading Canada-based bioengineering company, Renaissance BioScience (RBSC) recently announced its strategic partnership with the University of Saskatchewan’s Vaccine and Infectious Disease Organisation (VIDO) to target two viral diseases, as well as the immune system function in pigs and piglets, using RBSC's revolutionary yeast-based technology
